Tag Archives: Amarin
Cantor Fitzgerald Thinks Amarin’s Stock is Going to Recover
Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Amarin (NASDAQ: AMRN) today and set a price target of $10. The company’s shares closed yesterday at $3.10, close to its 52-week low of $2.82. Chen wrote: “Amarin announced the
Amarin Gets a Buy Rating from Cantor Fitzgerald
In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Amarin (NASDAQ: AMRN), with a price target of $10. The company’s shares closed yesterday at $2.93, close to its 52-week low of $2.82. Chen observed:
Cantor Fitzgerald Maintains Their Buy Rating on Amarin
In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Amarin (NASDAQ: AMRN), with a price target of $10. The company’s shares opened today at $3.66. Chen commented: “We like AMRN shares. The stock is
Cantor Fitzgerald Assigns a Buy Rating on Amarin
Cantor Fitzgerald analyst Louise Chen assigned a Buy rating to Amarin (NASDAQ: AMRN) today and set a price target of $10. The company’s shares opened today at $4.19. Chen wrote: “AMRN provided preliminary 2017 results and its 2018 outlook. The
Amarin Received its Third Buy in a Row
After SunTrust Robinson and H.C. Wainwright assigned a Buy rating to Amarin in the last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Louise Chen assigned a Buy rating to Amarin (NASDAQ: AMRN) today and set
Analysts’ Top Healthcare Picks: AMRN, BCRX
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amarin (NASDAQ: AMRN), BioCryst (NASDAQ: BCRX) and Abbott Labs (NYSE: ABT) with bullish sentiments. Amarin (NASDAQ: AMRN) Jefferies analyst Michael Yee reiterated
